Your browser doesn't support javascript.
loading
High levels of all-cause mortality among people who inject drugs from 2018 to 2022.
Roussos, Sotirios; Angelopoulos, Theodoros; Cholongitas, Evangelos; Savvanis, Spyridon; Papadopoulos, Nikolaos; Kapatais, Andreas; Chounta, Athina; Ioannidou, Panagiota; Deutsch, Melani; Manolakopoulos, Spilios; Sevastianos, Vasileios; Papageorgiou, Maria-Vasiliki; Vlachogiannakos, Ioannis; Mela, Maria; Elefsiniotis, Ioannis; Vrakas, Spyridon; Karagiannakis, Dimitrios; Pliarchopoulou, Fani; Chaikalis, Savvas; Tsirogianni, Effrosyni; Psichogiou, Mina; Kalamitsis, Georgios; Leobilla, Foteini; Paraskevis, Dimitrios; Malliori, Meni; Goulis, Ioannis; Papatheodoridis, Georgios; Hatzakis, Angelos; Sypsa, Vana.
Afiliação
  • Roussos S; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Angelopoulos T; Gastroenterology Resident, Gastroenterology Department, G.H.A. Korgialeneio Mpenakeio Hellenic Red Cross, Athens, Greece.
  • Cholongitas E; First Department of Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Savvanis S; Department of Internal Medicine, General Hospital of Athens "Elpis", Athens, Greece.
  • Papadopoulos N; 2nd Department of Internal Medicine, 401 General Army Hospital of Athens, Athens, Greece.
  • Kapatais A; 1st Department of Internal Medicine, Western Attica General Hospital "Agia Varvara", Athens, Greece.
  • Chounta A; 4th Department of Internal Medicine, General University Hospital "Attikon", Athens, Greece.
  • Ioannidou P; Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.
  • Deutsch M; 2nd Academic Department of Internal Medicine, Hippokration General Hospital, Athens, Greece.
  • Manolakopoulos S; 2nd Academic Department of Internal Medicine, Hippokration General Hospital, Athens, Greece.
  • Sevastianos V; 4th Department of Internal Medicine, Evangelismos General Hospital, Athens, Greece.
  • Papageorgiou MV; Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.
  • Vlachogiannakos I; Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.
  • Mela M; Department of Gastroenterology, Evangelismos General Hospital, Athens, Greece.
  • Elefsiniotis I; Department of Internal Medicine-Hepatogastroenterology, "Agioi Anargyroi" General and Oncology Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Vrakas S; Department of Gastroenterology, Tzaneion General Hospital of Piraeus, Piraeus, Greece.
  • Karagiannakis D; Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.
  • Pliarchopoulou F; 4th Department of Internal Medicine, General University Hospital "Attikon", Athens, Greece.
  • Chaikalis S; Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases, Athens, Greece.
  • Tsirogianni E; Fourth Department of Internal Medicine, Hippokratio Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Psichogiou M; First Department of Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Kalamitsis G; Hellenic Liver Patient Association "Prometheus", Athens, Greece.
  • Leobilla F; Municipality of Athens, Greece, Athens, Greece.
  • Paraskevis D; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Malliori M; Department of Psychiatry, National and Kapodistrian University of Athens, Athens, Greece.
  • Goulis I; Fourth Department of Internal Medicine, Hippokratio Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Papatheodoridis G; Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.
  • Hatzakis A; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases, Athens, Greece.
  • Sypsa V; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: vsipsa@med.uoa.gr.
Int J Drug Policy ; 126: 104356, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38394950
ABSTRACT

BACKGROUND:

Mortality among people who inject drugs (PWID) is high, with overdose and HIV infection being the main causes of death. In Greece, there have been no data on mortality, and two HIV outbreaks have been recorded in this population in the past decade. In this study, we aim to estimate the all-cause crude mortality rate and the standardised mortality ratio in this population during 2018-2022.

METHODS:

PWID recruited from two community-based programs in Athens and Thessaloniki during 2018-2021 were interviewed and tested for HIV/HCV. Data on vital status (deceased/alive) and date of death were obtained from death registries through December 31, 2022. All-cause crude mortality rates (CMR) and standardised mortality ratios (SMR) were estimated. Determinants of mortality were assessed using Cox proportional-hazards model.

RESULTS:

Of 2,530 participants, 301 died over 8,543 person-years (PYs) of follow-up. The CMR (95 % CI) was 3.52 (3.15-3.94) deaths per 100 PYs; 3.10 per 100 PYs (2.68-3.58) in Athens and 4.48 per 100 PYs (3.74-5.37) in Thessaloniki. An increasing trend in CMR was identified over 2018-2022 in Athens (from 2.90 to 4.11 per 100 PYs, 41.5 % increase, p = 0.018). The pooled SMR (95 % CI) was 15.86 (14.17-17.76) for both cities and was particularly increased in younger individuals, females, those injecting daily, not enrolled to opioid agonist treatment and HIV-infected individuals. Older age, living in Thessaloniki, Greek origin, homelessness, history of injection in the past 12 months, and HIV infection were independently associated with higher risk of death.

CONCLUSION:

Mortality among PWID in the two largest cities (Athens and Thessaloniki) in Greece in 2018-2022 was high, with the population in Thessaloniki being particularly affected. The increasing trend in mortality in Athens may reflect the long-term impact of the COVID-19 pandemic. Preventive programs such as take-home naloxone, screening and treatment for HIV, are urgently needed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Abuso de Substâncias por Via Intravenosa / Overdose de Drogas Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Int J Drug Policy Assunto da revista: SAUDE PUBLICA / TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Abuso de Substâncias por Via Intravenosa / Overdose de Drogas Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Int J Drug Policy Assunto da revista: SAUDE PUBLICA / TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Grécia